Article: Lack of effectiveness of magnesium in chronic stable asthma. A prospective, randomized, double-blind, placebo-controlled, crossover trial in normal subjects and in patients with chronic stable asthma.
1995 Volume 155, Issue 3, Page(s) 271–276
Abstract: ... Methods: We performed a prospective, randomized, double-blind, placebo-controlled, crossover trial in 15 ... We hypothesized that magnesium would also be an effective bronchodilator in patients with chronic stable asthma ... patients with chronic, stable asthma and 10 nonasthmatics. On study day 1, spirometry and albuterol ...
| Abstract | Background: Magnesium sulfate has been helpful in the treatment of acute exacerbations of asthma. We hypothesized that magnesium would also be an effective bronchodilator in patients with chronic stable asthma. Methods: We performed a prospective, randomized, double-blind, placebo-controlled, crossover trial in 15 patients with chronic, stable asthma and 10 nonasthmatics. On study day 1, spirometry and albuterol challenge were used to confirm the presence of asthma according to American Thoracic Society criteria. On study day 2, subjects received intravenous magnesium sulfate (2 g) or placebo (saline). On study day 3, subjects were crossed over to receive the other drug. Spirometry was performed before, during, and after drug or placebo administration. Circulating ionized magnesium concentrations were determined before and after intravenous magnesium or placebo administration. Results: Magnesium infusion caused no statistically significant changes in forced expiratory volume in 1 second (mean +/- SEM, 1.92 +/- 0.13 L before, 1.98 +/- 0.12 L during, and 2.01 +/- 0.14 L after magnesium administration), forced vital capacity (mean +/- SEM, 3.44 +/- 0.25 L before, 3.60 +/- 0.26 L during, and 3.59 +/- 0.25 L after magnesium administration), or maximum forced expiratory flow rate (mean +/- SEM, 5.42 +/- 0.44 L/second before, 5.46 +/- 0.46 L/second during, and 5.57 +/- 0.49 L/second after magnesium administration). Placebo caused no changes in these three physiologic variables. Conclusion: Magnesium is not effective as a bronchodilator in chronic, stable asthmatics or in normal non-asthmatic adults. |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MeSH term(s) | Adult ; Asthma/blood ; Asthma/drug therapy ; Asthma/physiopathology ; Chronic Disease ; Double-Blind Method ; Female ; Humans ; Magnesium Sulfate/therapeutic use ; Male ; Prospective Studies ; Respiratory Function Tests ; Treatment Failure | ||||||||||
| Chemical Substances | Magnesium Sulfate (7487-88-9) | ||||||||||
| Language | English | ||||||||||
| Publishing date | 1995-02-13 | ||||||||||
| Publishing country | United States | ||||||||||
| Document type | Clinical Trial ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't | ||||||||||
| ZDB-ID | 211575-x | ||||||||||
| ISSN | 1538-3679 ; 0003-9926 ; 0888-2479 ; 0730-188X | ||||||||||
| ISSN (online) | 1538-3679 | ||||||||||
| ISSN | 0003-9926 ; 0888-2479 ; 0730-188X | ||||||||||
| DOI | 10.1001/archinte.155.3.271 | ||||||||||
| Shelf mark |
|
||||||||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ua VI Zs.119: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MA 14: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.